Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Metric partnerships: global burden of disease estimates within the World Bank, the World Health Organisation and the Institute for Health Metrics and Evaluation.

Tichenor M, Sridhar D.

Wellcome Open Res. 2019 Feb 18;4:35. doi: 10.12688/wellcomeopenres.15011.1. eCollection 2019.

2.

Global health security and universal health coverage: from a marriage of convenience to a strategic, effective partnership.

Wenham C, Katz R, Birungi C, Boden L, Eccleston-Turner M, Gostin L, Guinto R, Hellowell M, Onarheim KH, Hutton J, Kapilashrami A, Mendenhall E, Phelan A, Tichenor M, Sridhar D.

BMJ Glob Health. 2019 Jan 13;4(1):e001145. doi: 10.1136/bmjgh-2018-001145. eCollection 2019.

3.

Universal health coverage, health systems strengthening, and the World Bank.

Tichenor M, Sridhar D.

BMJ. 2017 Aug 31;358:j3347. doi: 10.1136/bmj.j3347. No abstract available.

4.

Data Performativity, Performing Health Work: Malaria and Labor in Senegal.

Tichenor M.

Med Anthropol. 2017 Jul;36(5):436-448. doi: 10.1080/01459740.2017.1316722. Epub 2017 Apr 10.

PMID:
28394640
5.

The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors.

Keith JM, Tichenor MS, Apodaca RL, Xiao W, Jones WM, Seierstad M, Pierce JM, Palmer JA, Webb M, Karbarz MJ, Scott BP, Wilson SJ, Wennerholm ML, Rizzolio M, Rynberg R, Chaplan SR, Breitenbucher JG.

Bioorg Med Chem Lett. 2016 Jul 1;26(13):3109-3114. doi: 10.1016/j.bmcl.2016.05.001. Epub 2016 May 5.

PMID:
27189675
6.

Preclinical Characterization of the FAAH Inhibitor JNJ-42165279.

Keith JM, Jones WM, Tichenor M, Liu J, Seierstad M, Palmer JA, Webb M, Karbarz M, Scott BP, Wilson SJ, Luo L, Wennerholm ML, Chang L, Rizzolio M, Rynberg R, Chaplan SR, Breitenbucher JG.

ACS Med Chem Lett. 2015 Nov 2;6(12):1204-8. doi: 10.1021/acsmedchemlett.5b00353. eCollection 2015 Dec 10.

7.

Functional Profiling of 2-Aminopyrimidine Histamine H4 Receptor Modulators.

Tichenor MS, Thurmond RL, Venable JD, Savall BM.

J Med Chem. 2015 Sep 24;58(18):7119-27. doi: 10.1021/acs.jmedchem.5b00516. Epub 2015 Jun 3. Review.

PMID:
25993395
8.

A proposed role for efflux transporters in the pathogenesis of hydrocephalus.

Krishnamurthy S, Tichenor MD, Satish AG, Lehmann DB.

Croat Med J. 2014 Aug 28;55(4):366-76. Review.

9.

Hydrothermal synthesis, structure and magnetic properties of a three-dimensional cobalt(II) - aminophenyltetrazolate coordination polymer.

Smith TM, Tichenor M, Zhang YZ, Dunbar KR, Zubieta J.

Dalton Trans. 2014 May 21;43(19):7263-8. doi: 10.1039/c4dt00456f. Epub 2014 Mar 31.

PMID:
24681873
10.

Heteroaryl urea inhibitors of fatty acid amide hydrolase: structure-mutagenicity relationships for arylamine metabolites.

Tichenor MS, Keith JM, Jones WM, Pierce JM, Merit J, Hawryluk N, Seierstad M, Palmer JA, Webb M, Karbarz MJ, Wilson SJ, Wennerholm ML, Woestenborghs F, Beerens D, Luo L, Brown SM, Boeck MD, Chaplan SR, Breitenbucher JG.

Bioorg Med Chem Lett. 2012 Dec 15;22(24):7357-62. doi: 10.1016/j.bmcl.2012.10.076. Epub 2012 Oct 22.

PMID:
23141911
11.

Radiation risk due to shunted hydrocephalus and the role of MR imaging-safe programmable valves.

Krishnamurthy S, Schmidt B, Tichenor MD.

AJNR Am J Neuroradiol. 2013 Apr;34(4):695-7. doi: 10.3174/ajnr.A3334. Epub 2012 Nov 1. No abstract available.

12.

Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate.

Keith JM, Apodaca R, Tichenor M, Xiao W, Jones W, Pierce J, Seierstad M, Palmer J, Webb M, Karbarz M, Scott B, Wilson S, Luo L, Wennerholm M, Chang L, Brown S, Rizzolio M, Rynberg R, Chaplan S, Breitenbucher JG.

ACS Med Chem Lett. 2012 Aug 22;3(10):823-7. doi: 10.1021/ml300186g. eCollection 2012 Oct 11.

13.

Yatakemycin: total synthesis, DNA alkylation, and biological properties.

Tichenor MS, Boger DL.

Nat Prod Rep. 2008 Apr;25(2):220-6. doi: 10.1039/b705665f. Epub 2007 Nov 6.

PMID:
18389136
14.

Rational design, synthesis, and evaluation of key analogues of CC-1065 and the duocarmycins.

Tichenor MS, MacMillan KS, Stover JS, Wolkenberg SE, Pavani MG, Zanella L, Zaid AN, Spalluto G, Rayl TJ, Hwang I, Baraldi PG, Boger DL.

J Am Chem Soc. 2007 Nov 14;129(45):14092-9. Epub 2007 Oct 19.

15.

Systematic exploration of the structural features of yatakemycin impacting DNA alkylation and biological activity.

Tichenor MS, MacMillan KS, Trzupek JD, Rayl TJ, Hwang I, Boger DL.

J Am Chem Soc. 2007 Sep 5;129(35):10858-69. Epub 2007 Aug 11.

16.

Asymmetric total synthesis of (+)- and ent-(-)-yatakemycin and duocarmycin SA: evaluation of yatakemycin key partial structures and its unnatural enantiomer.

Tichenor MS, Trzupek JD, Kastrinsky DB, Shiga F, Hwang I, Boger DL.

J Am Chem Soc. 2006 Dec 13;128(49):15683-96.

17.

Total synthesis, structure revision, and absolute configuration of (+)-yatakemycin.

Tichenor MS, Kastrinsky DB, Boger DL.

J Am Chem Soc. 2004 Jul 14;126(27):8396-8.

PMID:
15237994
18.

Ruthenium-mediated cycloaromatization of acyclic enediynes and dienynes at ambient temperature.

O'Connor JM, Friese SJ, Tichenor M.

J Am Chem Soc. 2002 Apr 10;124(14):3506-7.

PMID:
11929230

Supplemental Content

Loading ...
Support Center